Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 791 entries
Sorted by: Best Match Show Resources per page
Introduction to the National Institute of Health: its development in the past twenty years.

Japanese journal of medical science & biology

Yanagisawa K.
PMID: 4860719
Jpn J Med Sci Biol. 1967 Feb;20(1):1-14. doi: 10.7883/yoken1952.20.1.

No abstract available.

Cite
Yanagisawa K. Introduction to the National Institute of Health: its development in the past twenty years. Jpn J Med Sci Biol. 1967;20(1):1-14doi: 10.7883/yoken1952.20.1.
Yanagisawa, K. (1967). Introduction to the National Institute of Health: its development in the past twenty years. Japanese journal of medical science & biology, 20(1), 1-14. https://doi.org/10.7883/yoken1952.20.1
Yanagisawa, K. "Introduction to the National Institute of Health: its development in the past twenty years." Japanese journal of medical science & biology vol. 20,1 (1967): 1-14. doi: https://doi.org/10.7883/yoken1952.20.1
Yanagisawa K. Introduction to the National Institute of Health: its development in the past twenty years. Jpn J Med Sci Biol. 1967 Feb;20(1):1-14. doi: 10.7883/yoken1952.20.1. PMID: 4860719.
Copy Download .nbib Format: NLM
Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse.

Molecular neurodegeneration

Takamura A, Okamoto Y, Kawarabayashi T, Yokoseki T, Shibata M, Mouri A, Nabeshima T, Sun H, Abe K, Urisu T, Yamamoto N, Shoji M, Yanagisawa K, Michikawa M, Matsubara E.
PMID: 21375782
Mol Neurodegener. 2011 Mar 06;6(1):20. doi: 10.1186/1750-1326-6-20.

BACKGROUND: Several lines of evidence indicate that memory loss represents a synaptic failure caused by soluble amyloid β (Aβ) oligomers. However, the pathological relevance of Aβ oligomers (AβOs) as the trigger of synaptic or neuronal degeneration, and the possible...

Cite
Takamura A, Okamoto Y, Kawarabayashi T, et al. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Mol Neurodegener. 2011;6(1):20doi: 10.1186/1750-1326-6-20.
Takamura, A., Okamoto, Y., Kawarabayashi, T., Yokoseki, T., Shibata, M., Mouri, A., Nabeshima, T., Sun, H., Abe, K., Urisu, T., Yamamoto, N., Shoji, M., Yanagisawa, K., Michikawa, M., & Matsubara, E. (2011). Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Molecular neurodegeneration, 6(1), 20. https://doi.org/10.1186/1750-1326-6-20
Takamura, Ayumi, et al. "Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse." Molecular neurodegeneration vol. 6,1 (2011): 20. doi: https://doi.org/10.1186/1750-1326-6-20
Takamura A, Okamoto Y, Kawarabayashi T, Yokoseki T, Shibata M, Mouri A, Nabeshima T, Sun H, Abe K, Urisu T, Yamamoto N, Shoji M, Yanagisawa K, Michikawa M, Matsubara E. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Mol Neurodegener. 2011 Mar 06;6(1):20. doi: 10.1186/1750-1326-6-20. PMID: 21375782; PMCID: PMC3061944.
Copy Download .nbib Format: NLM
Optical Control of Young's Type Double-slit Interferometer for Laser-induced Electron Emission from a Nano-tip.

Scientific reports

Yanagisawa H, Ciappina M, Hafner C, Schötz J, Osterwalder J, Kling MF.
PMID: 28978914
Sci Rep. 2017 Oct 04;7(1):12661. doi: 10.1038/s41598-017-12832-3.

Interference experiments with electrons in a vacuum can illuminate both the quantum and the nanoscale nature of the underlying physics. An interference experiment requires two coherent waves, which can be generated by splitting a single coherent wave using a...

Cite
Yanagisawa H, Ciappina M, Hafner C, et al. Optical Control of Young's Type Double-slit Interferometer for Laser-induced Electron Emission from a Nano-tip. Sci Rep. 2017;7(1):12661doi: 10.1038/s41598-017-12832-3.
Yanagisawa, H., Ciappina, M., Hafner, C., Schötz, J., Osterwalder, J., & Kling, M. F. (2017). Optical Control of Young's Type Double-slit Interferometer for Laser-induced Electron Emission from a Nano-tip. Scientific reports, 7(1), 12661. https://doi.org/10.1038/s41598-017-12832-3
Yanagisawa, Hirofumi, et al. "Optical Control of Young's Type Double-slit Interferometer for Laser-induced Electron Emission from a Nano-tip." Scientific reports vol. 7,1 (2017): 12661. doi: https://doi.org/10.1038/s41598-017-12832-3
Yanagisawa H, Ciappina M, Hafner C, Schötz J, Osterwalder J, Kling MF. Optical Control of Young's Type Double-slit Interferometer for Laser-induced Electron Emission from a Nano-tip. Sci Rep. 2017 Oct 04;7(1):12661. doi: 10.1038/s41598-017-12832-3. PMID: 28978914; PMCID: PMC5627254.
Copy Download .nbib Format: NLM
Atazanavir nephrotoxicity.

Clinical kidney journal

Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M.
PMID: 25815168
Clin Kidney J. 2015 Apr;8(2):137-42. doi: 10.1093/ckj/sfv015. Epub 2015 Mar 20.

Atazanavir is commonly used as one of the key drugs in combination antiretroviral therapy for human immunodeficiency virus (HIV). However, atazanavir has the potential to yield its crystalline precipitation in urine and renal interstitial tissues, leading to crystalluria, urolithiasis,...

Cite
Hara M, Suganuma A, Yanagisawa N, et al. Atazanavir nephrotoxicity. Clin Kidney J. 2015;8(2):137-42doi: 10.1093/ckj/sfv015.
Hara, M., Suganuma, A., Yanagisawa, N., Imamura, A., Hishima, T., & Ando, M. (2015). Atazanavir nephrotoxicity. Clinical kidney journal, 8(2), 137-42. https://doi.org/10.1093/ckj/sfv015
Hara, Masaki, et al. "Atazanavir nephrotoxicity." Clinical kidney journal vol. 8,2 (2015): 137-42. doi: https://doi.org/10.1093/ckj/sfv015
Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M. Atazanavir nephrotoxicity. Clin Kidney J. 2015 Apr;8(2):137-42. doi: 10.1093/ckj/sfv015. Epub 2015 Mar 20. PMID: 25815168; PMCID: PMC4370314.
Copy Download .nbib Format: NLM
Semi Quantification of Gibberellins in the Anthers of Thermosensitive Genetic Male Sterile Rice (Oryza sativa L. cv. PL12).

Bioscience, biotechnology, and biochemistry

Honda I, Iwasaki S, Sudo K, Kato H, Maruyama K, Hasegawa M, Yamaguchi I, Murofushi N, Yanagisawa T, Takahashi N.
PMID: 27393172
Biosci Biotechnol Biochem. 1997 Jan;61(10):1748-50. doi: 10.1271/bbb.61.1748.

The levels of endogenous GAs in the anthers of rice (Oryza sativa L., cv. Reimei (normal)) and in those of sterile and fertile plants of a thermosensitive genetic male sterile line (Norin PL12; derived from Reimei) were measured by...

Cite
Honda I, Iwasaki S, Sudo K, et al. Semi Quantification of Gibberellins in the Anthers of Thermosensitive Genetic Male Sterile Rice (Oryza sativa L. cv. PL12). Biosci Biotechnol Biochem. 1997;61(10):1748-50doi: 10.1271/bbb.61.1748.
Honda, I., Iwasaki, S., Sudo, K., Kato, H., Maruyama, K., Hasegawa, M., Yamaguchi, I., Murofushi, N., Yanagisawa, T., & Takahashi, N. (1997). Semi Quantification of Gibberellins in the Anthers of Thermosensitive Genetic Male Sterile Rice (Oryza sativa L. cv. PL12). Bioscience, biotechnology, and biochemistry, 61(10), 1748-50. https://doi.org/10.1271/bbb.61.1748
Honda, I, et al. "Semi Quantification of Gibberellins in the Anthers of Thermosensitive Genetic Male Sterile Rice (Oryza sativa L. cv. PL12)." Bioscience, biotechnology, and biochemistry vol. 61,10 (1997): 1748-50. doi: https://doi.org/10.1271/bbb.61.1748
Honda I, Iwasaki S, Sudo K, Kato H, Maruyama K, Hasegawa M, Yamaguchi I, Murofushi N, Yanagisawa T, Takahashi N. Semi Quantification of Gibberellins in the Anthers of Thermosensitive Genetic Male Sterile Rice (Oryza sativa L. cv. PL12). Biosci Biotechnol Biochem. 1997 Jan;61(10):1748-50. doi: 10.1271/bbb.61.1748. PMID: 27393172.
Copy Download .nbib Format: NLM
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society.

Esophagus : official journal of the Japan Esophageal Society

Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A.
PMID: 25620903
Esophagus. 2015;12:1-30. doi: 10.1007/s10388-014-0465-1. Epub 2014 Nov 11.

No abstract available.

Cite
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2014;12:1-30doi: 10.1007/s10388-014-0465-1.
Kuwano, H., Nishimura, Y., Oyama, T., Kato, H., Kitagawa, Y., Kusano, M., Shimada, H., Takiuchi, H., Toh, Y., Doki, Y., Naomoto, Y., Matsubara, H., Miyazaki, T., Muto, M., & Yanagisawa, A. (2015). Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus : official journal of the Japan Esophageal Society, 121-30. https://doi.org/10.1007/s10388-014-0465-1
Kuwano, Hiroyuki, et al. "Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society." Esophagus : official journal of the Japan Esophageal Society vol. 12 (2015): 1-30. doi: https://doi.org/10.1007/s10388-014-0465-1
Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1-30. doi: 10.1007/s10388-014-0465-1. Epub 2014 Nov 11. PMID: 25620903; PMCID: PMC4297610.
Copy Download .nbib Format: NLM
Proposal of auxiliary diagnosis index for autism spectrum disorder using near-infrared spectroscopy.

Neurophotonics

Yanagisawa K, Nakamura N, Tsunashima H, Narita N.
PMID: 27335890
Neurophotonics. 2016 Jul;3(3):031413. doi: 10.1117/1.NPh.3.3.031413. Epub 2016 Jun 09.

Lack of a diagnostic index is a problem that needs to be overcome in the diagnosis of autism spectrum disorder (ASD), because this problem prevents an objective assessment based on biomarkers. This paper describes the development of a diagnostic...

Cite
Yanagisawa K, Nakamura N, Tsunashima H, et al. Proposal of auxiliary diagnosis index for autism spectrum disorder using near-infrared spectroscopy. Neurophotonics. 2016;3(3):031413doi: 10.1117/1.NPh.3.3.031413.
Yanagisawa, K., Nakamura, N., Tsunashima, H., & Narita, N. (2016). Proposal of auxiliary diagnosis index for autism spectrum disorder using near-infrared spectroscopy. Neurophotonics, 3(3), 031413. https://doi.org/10.1117/1.NPh.3.3.031413
Yanagisawa, Kazuki, et al. "Proposal of auxiliary diagnosis index for autism spectrum disorder using near-infrared spectroscopy." Neurophotonics vol. 3,3 (2016): 031413. doi: https://doi.org/10.1117/1.NPh.3.3.031413
Yanagisawa K, Nakamura N, Tsunashima H, Narita N. Proposal of auxiliary diagnosis index for autism spectrum disorder using near-infrared spectroscopy. Neurophotonics. 2016 Jul;3(3):031413. doi: 10.1117/1.NPh.3.3.031413. Epub 2016 Jun 09. PMID: 27335890; PMCID: PMC4900044.
Copy Download .nbib Format: NLM
Adjusting the Chemical Bonding of SnO.

Small (Weinheim an der Bergstrasse, Germany)

Cheng Y, Huang J, Qi H, Cao L, Yang J, Xi Q, Luo X, Yanagisawa K, Li J.
PMID: 28640435
Small. 2017 Aug;13(31). doi: 10.1002/smll.201700656. Epub 2017 Jun 22.

Carbon nanotubes (CNTs) with excellent electron conductivity are widely used to improve the electrochemical performance of the SnO

Cite
Cheng Y, Huang J, Qi H, et al. Adjusting the Chemical Bonding of SnO. Small. 2017;13(31)doi: 10.1002/smll.201700656.
Cheng, Y., Huang, J., Qi, H., Cao, L., Yang, J., Xi, Q., Luo, X., Yanagisawa, K., & Li, J. (2017). Adjusting the Chemical Bonding of SnO. Small (Weinheim an der Bergstrasse, Germany), 13(31), . https://doi.org/10.1002/smll.201700656
Cheng, Yayi, et al. "Adjusting the Chemical Bonding of SnO." Small (Weinheim an der Bergstrasse, Germany) vol. 13,31 (2017). doi: https://doi.org/10.1002/smll.201700656
Cheng Y, Huang J, Qi H, Cao L, Yang J, Xi Q, Luo X, Yanagisawa K, Li J. Adjusting the Chemical Bonding of SnO. Small. 2017 Aug;13(31). doi: 10.1002/smll.201700656. Epub 2017 Jun 22. PMID: 28640435.
Copy Download .nbib Format: NLM
Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.

Oncology letters

Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T.
PMID: 28599481
Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21.

Patients with pancreatic ductal adenocarcinoma (PDA) typically succumb to mortality early, even following surgical resection. Therefore, prognostic factors associated with early mortality are required to improve the survival of patients with PDA following surgical resection. Carbohydrate sulfotransferase 15 (CHST15)...

Cite
Ito Z, Takakura K, Suka M, et al. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(6):4799-4805doi: 10.3892/ol.2017.6071.
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., Koido, S., & Ohkusa, T. (2017). Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncology letters, 13(6), 4799-4805. https://doi.org/10.3892/ol.2017.6071
Ito, Zensho, et al. "Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma." Oncology letters vol. 13,6 (2017): 4799-4805. doi: https://doi.org/10.3892/ol.2017.6071
Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21. PMID: 28599481; PMCID: PMC5453115.
Copy Download .nbib Format: NLM
Dexmedetomidine use during epiduroscopy reduces fentanyl use and postoperative nausea and vomiting: A single-center retrospective study.

SAGE open medicine

Suzuki T, Inokuchi R, Hanaoka K, Suka M, Yanagisawa H.
PMID: 29449944
SAGE Open Med. 2018 Feb 09;6:2050312118756804. doi: 10.1177/2050312118756804. eCollection 2018.

OBJECTIVES: Minimally invasive epiduroscopy has recently been reported as an effective treatment procedure for chronic and intractable low back pain. However, no study has determined safe anesthetics for monitored anesthesia care during epiduroscopy. We aimed to compare and evaluate...

Cite
Suzuki T, Inokuchi R, Hanaoka K, et al. Dexmedetomidine use during epiduroscopy reduces fentanyl use and postoperative nausea and vomiting: A single-center retrospective study. SAGE Open Med. 2018;6:2050312118756804doi: 10.1177/2050312118756804.
Suzuki, T., Inokuchi, R., Hanaoka, K., Suka, M., & Yanagisawa, H. (2018). Dexmedetomidine use during epiduroscopy reduces fentanyl use and postoperative nausea and vomiting: A single-center retrospective study. SAGE open medicine, 62050312118756804. https://doi.org/10.1177/2050312118756804
Suzuki, Takashi, et al. "Dexmedetomidine use during epiduroscopy reduces fentanyl use and postoperative nausea and vomiting: A single-center retrospective study." SAGE open medicine vol. 6 (2018): 2050312118756804. doi: https://doi.org/10.1177/2050312118756804
Suzuki T, Inokuchi R, Hanaoka K, Suka M, Yanagisawa H. Dexmedetomidine use during epiduroscopy reduces fentanyl use and postoperative nausea and vomiting: A single-center retrospective study. SAGE Open Med. 2018 Feb 09;6:2050312118756804. doi: 10.1177/2050312118756804. eCollection 2018. PMID: 29449944; PMCID: PMC5808957.
Copy Download .nbib Format: NLM
Microdissection of plant chromosomes by argon-ion laser beam.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Fukui K, Minezawa M, Kamisugi Y, Ishikawa M, Ohmido N, Yanagisawa T, Fujishita M, Sakai F.
PMID: 24201475
Theor Appl Genet. 1992 Sep;84(7):787-91. doi: 10.1007/BF00227385.

Rice and barley chromosomal samples were prepared both on a polyester membrane and on an ordinary glass slide and subjected to microdissection by an argon-ion laser. The intensity and the position of the laser beam were controlled by a...

Cite
Fukui K, Minezawa M, Kamisugi Y, et al. Microdissection of plant chromosomes by argon-ion laser beam. Theor Appl Genet. 1992;84(7):787-91doi: 10.1007/BF00227385.
Fukui, K., Minezawa, M., Kamisugi, Y., Ishikawa, M., Ohmido, N., Yanagisawa, T., Fujishita, M., & Sakai, F. (1992). Microdissection of plant chromosomes by argon-ion laser beam. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 84(7), 787-91. https://doi.org/10.1007/BF00227385
Fukui, K, et al. "Microdissection of plant chromosomes by argon-ion laser beam." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 84,7 (1992): 787-91. doi: https://doi.org/10.1007/BF00227385
Fukui K, Minezawa M, Kamisugi Y, Ishikawa M, Ohmido N, Yanagisawa T, Fujishita M, Sakai F. Microdissection of plant chromosomes by argon-ion laser beam. Theor Appl Genet. 1992 Sep;84(7):787-91. doi: 10.1007/BF00227385. PMID: 24201475.
Copy Download .nbib Format: NLM
Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.

Molecular and clinical oncology

Harada S, Yanagisawa M, Kaneko S, Yorozu K, Yamamoto K, Moriya Y, Harada N.
PMID: 26623038
Mol Clin Oncol. 2015 Sep;3(5):987-994. doi: 10.3892/mco.2015.609. Epub 2015 Jul 21.

In the treatment of human epidermal growth factor receptor 2 (HER2)-positive advanced gastric or gastroesophageal junction cancer, it has been reported that the combination of trastuzumab with capecitabine plus cisplatin, or with 5-fluorouracil (5-FU) plus cisplatin, significantly increased overall...

Cite
Harada S, Yanagisawa M, Kaneko S, et al. Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model. Mol Clin Oncol. 2015;3(5):987-994doi: 10.3892/mco.2015.609.
Harada, S., Yanagisawa, M., Kaneko, S., Yorozu, K., Yamamoto, K., Moriya, Y., & Harada, N. (2015). Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model. Molecular and clinical oncology, 3(5), 987-994. https://doi.org/10.3892/mco.2015.609
Harada, Suguru, et al. "Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model." Molecular and clinical oncology vol. 3,5 (2015): 987-994. doi: https://doi.org/10.3892/mco.2015.609
Harada S, Yanagisawa M, Kaneko S, Yorozu K, Yamamoto K, Moriya Y, Harada N. Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model. Mol Clin Oncol. 2015 Sep;3(5):987-994. doi: 10.3892/mco.2015.609. Epub 2015 Jul 21. PMID: 26623038; PMCID: PMC4534867.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 791 entries